The health impacts of men losing their Y chromosome from their cells are increasingly coming to light, with the loss playing ...

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

A year after she quit smoking, Kim Swart thought the half-million cigarettes she smoked between high school and retirement ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

ImPact Biotech is an advanced clinical-stage oncology company focused on the development and commercialization of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, a minimally invasive ...

Using AI and big data, Weizmann Institute researchers build MiTEs, or natural killer/T-cell Enhancers, to combat cancers, 5 ...

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...

Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focused on the application of next ...

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...